Georg Schett, known for CAR-T work, moves in a new direction
Georg SchettBoulevard Bio
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis.01.
Over the last five years, German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment, showing that CAR-T therapy could be used to reset patients’ immune systems.
He has become a scientific adviser de rigueur for the field, joining a half-dozen startup advisory boards.
